This variant was previously confirmed as a somatic variant in patients affected by breast carcinoma of different histological subtypes, and in a series of other cancer types (e.g., colorectal, brain, lung, and ovarian), according to the IARC TP53 database and the COSMIC database. This evidence concerns the gene TP53 and cancer.